A thyroid hormone antagonist that inhibits thyroid hormone action in vivo

Wayland Lim, Ngoc Ha Nguyen, Ha Yung Yang, Thomas (Tom) Scanlan, J. David Furlow

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

We have characterized the newly developed thyroid hormone antagonist NH-3 in both cell culture and in vivo model systems. NH-3 binds Xenopus laevis thyroid hormone receptors directly in vitro and induces a conformation distinct from agonist-bound receptors. Transcriptional activation of a thyroid hormone response element-containing reporter gene is strongly inhibited by NH-3 in a dose-dependent manner. In addition, NH-3 prevents X. laevis thyroid hormone receptors from binding to the p160 family of co-activators GRIP-1 and SRC-1 in a two-hybrid assay. To assess the potency of the compound in vivo, we used induced and spontaneous X. laevis tadpole metamorphosis, a thyroid hormone-dependent developmental process. NH-3 inhibits thyroid hormone-induced morphological changes in a dose-dependent manner and inhibits the up-regulation of endogenous thyroid hormone-responsive genes. Spontaneous metamorphosis is efficiently and reversibly arrested by NH-3 with at least the same effectiveness as the thyroid hormone synthesis inhibitor methimazole. Therefore, NH-3 is the first thyroid hormone antagonist to demonstrate potent inhibition of thyroid hormone action in both cell culture- and whole animal-based assays.

Original languageEnglish (US)
Pages (from-to)35664-35670
Number of pages7
JournalJournal of Biological Chemistry
Volume277
Issue number38
DOIs
StatePublished - Sep 20 2002
Externally publishedYes

Fingerprint

Hormone Antagonists
Antithyroid Agents
Thyroid Hormones
Xenopus laevis
Thyroid Hormone Receptors
Cell culture
Assays
Cell Culture Techniques
Genes
Methimazole
Two-Hybrid System Techniques
Response Elements
Reporter Genes
Transcriptional Activation
Larva
Conformations
Animals
Up-Regulation
Chemical activation

ASJC Scopus subject areas

  • Biochemistry

Cite this

A thyroid hormone antagonist that inhibits thyroid hormone action in vivo. / Lim, Wayland; Nguyen, Ngoc Ha; Yang, Ha Yung; Scanlan, Thomas (Tom); David Furlow, J.

In: Journal of Biological Chemistry, Vol. 277, No. 38, 20.09.2002, p. 35664-35670.

Research output: Contribution to journalArticle

Lim, Wayland ; Nguyen, Ngoc Ha ; Yang, Ha Yung ; Scanlan, Thomas (Tom) ; David Furlow, J. / A thyroid hormone antagonist that inhibits thyroid hormone action in vivo. In: Journal of Biological Chemistry. 2002 ; Vol. 277, No. 38. pp. 35664-35670.
@article{cd438d05af85458988e5dae9ef409611,
title = "A thyroid hormone antagonist that inhibits thyroid hormone action in vivo",
abstract = "We have characterized the newly developed thyroid hormone antagonist NH-3 in both cell culture and in vivo model systems. NH-3 binds Xenopus laevis thyroid hormone receptors directly in vitro and induces a conformation distinct from agonist-bound receptors. Transcriptional activation of a thyroid hormone response element-containing reporter gene is strongly inhibited by NH-3 in a dose-dependent manner. In addition, NH-3 prevents X. laevis thyroid hormone receptors from binding to the p160 family of co-activators GRIP-1 and SRC-1 in a two-hybrid assay. To assess the potency of the compound in vivo, we used induced and spontaneous X. laevis tadpole metamorphosis, a thyroid hormone-dependent developmental process. NH-3 inhibits thyroid hormone-induced morphological changes in a dose-dependent manner and inhibits the up-regulation of endogenous thyroid hormone-responsive genes. Spontaneous metamorphosis is efficiently and reversibly arrested by NH-3 with at least the same effectiveness as the thyroid hormone synthesis inhibitor methimazole. Therefore, NH-3 is the first thyroid hormone antagonist to demonstrate potent inhibition of thyroid hormone action in both cell culture- and whole animal-based assays.",
author = "Wayland Lim and Nguyen, {Ngoc Ha} and Yang, {Ha Yung} and Scanlan, {Thomas (Tom)} and {David Furlow}, J.",
year = "2002",
month = "9",
day = "20",
doi = "10.1074/jbc.M205608200",
language = "English (US)",
volume = "277",
pages = "35664--35670",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "38",

}

TY - JOUR

T1 - A thyroid hormone antagonist that inhibits thyroid hormone action in vivo

AU - Lim, Wayland

AU - Nguyen, Ngoc Ha

AU - Yang, Ha Yung

AU - Scanlan, Thomas (Tom)

AU - David Furlow, J.

PY - 2002/9/20

Y1 - 2002/9/20

N2 - We have characterized the newly developed thyroid hormone antagonist NH-3 in both cell culture and in vivo model systems. NH-3 binds Xenopus laevis thyroid hormone receptors directly in vitro and induces a conformation distinct from agonist-bound receptors. Transcriptional activation of a thyroid hormone response element-containing reporter gene is strongly inhibited by NH-3 in a dose-dependent manner. In addition, NH-3 prevents X. laevis thyroid hormone receptors from binding to the p160 family of co-activators GRIP-1 and SRC-1 in a two-hybrid assay. To assess the potency of the compound in vivo, we used induced and spontaneous X. laevis tadpole metamorphosis, a thyroid hormone-dependent developmental process. NH-3 inhibits thyroid hormone-induced morphological changes in a dose-dependent manner and inhibits the up-regulation of endogenous thyroid hormone-responsive genes. Spontaneous metamorphosis is efficiently and reversibly arrested by NH-3 with at least the same effectiveness as the thyroid hormone synthesis inhibitor methimazole. Therefore, NH-3 is the first thyroid hormone antagonist to demonstrate potent inhibition of thyroid hormone action in both cell culture- and whole animal-based assays.

AB - We have characterized the newly developed thyroid hormone antagonist NH-3 in both cell culture and in vivo model systems. NH-3 binds Xenopus laevis thyroid hormone receptors directly in vitro and induces a conformation distinct from agonist-bound receptors. Transcriptional activation of a thyroid hormone response element-containing reporter gene is strongly inhibited by NH-3 in a dose-dependent manner. In addition, NH-3 prevents X. laevis thyroid hormone receptors from binding to the p160 family of co-activators GRIP-1 and SRC-1 in a two-hybrid assay. To assess the potency of the compound in vivo, we used induced and spontaneous X. laevis tadpole metamorphosis, a thyroid hormone-dependent developmental process. NH-3 inhibits thyroid hormone-induced morphological changes in a dose-dependent manner and inhibits the up-regulation of endogenous thyroid hormone-responsive genes. Spontaneous metamorphosis is efficiently and reversibly arrested by NH-3 with at least the same effectiveness as the thyroid hormone synthesis inhibitor methimazole. Therefore, NH-3 is the first thyroid hormone antagonist to demonstrate potent inhibition of thyroid hormone action in both cell culture- and whole animal-based assays.

UR - http://www.scopus.com/inward/record.url?scp=0037144443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037144443&partnerID=8YFLogxK

U2 - 10.1074/jbc.M205608200

DO - 10.1074/jbc.M205608200

M3 - Article

C2 - 12095994

AN - SCOPUS:0037144443

VL - 277

SP - 35664

EP - 35670

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 38

ER -